SCHEMBL18273533

SCHEMBL18273533

c1ccc(-c2ccc3c(c2)c2c(-c4nc(-c5cccc6c5oc5ccccc56)c5c(n4)oc4ccccc45)cccc2n3-c2ccccc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.35
SMN1; SMN2 Q16637 4/20 0.34
LMNA P02545 2/20 0.34
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PRKDC P78527 2/20 0.32
NPC1 O15118 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
RAB9A P51151 1/20 0.31
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
PIK3CD O00329 1/20 0.30
PIK3CB P42338 1/20 0.30
PTGES2 Q9H7Z7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18273534 0.92 ALOX5 (0.36) ALOX5SMN1; SMN2LMNAALDH1A1CYP1A2
SCHEMBL18273536 0.91 SMN1; SMN2 (0.39) ALOX5SMN1; SMN2LMNAALDH1A1CYP1A2
SCHEMBL20029872 0.89 ALOX5 (0.36) ALOX5SMN1; SMN2LMNAALDH1A1CYP1A2
SCHEMBL18273530 0.89 ALOX5 (0.37) ALOX5SMN1; SMN2LMNAALDH1A1CYP1A2
SCHEMBL18273203 0.89 ALOX5 (0.35) ALOX5LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL18273427 0.87 ALOX5 (0.34) ALOX5PRKDCPIM1CSNK2A2CSNK2B
SCHEMBL17252778 0.86 ALOX5 (0.40) ALOX5LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL18273538 0.86 PRKDC (0.33) ALOX5SMN1; SMN2LMNAALDH1A1CYP1A2
SCHEMBL24388313 0.86 SMN1; SMN2 (0.35) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL18273507 0.86 SMN1; SMN2 (0.35) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 1855/4885SMN1; SMN2 4723/4885LMNA 1491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.